Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients.
Berends AMA, Bolhuis MS, Nolte IM, Buitenwerf E, Links TP, Timmers HJLM, Feelders RA, Eekhoff EMW, Corssmit EPM, Bisschop PH, Haak HR, van Schaik RHN, El Bouazzaoui S, Wilffert B, Kerstens MN. Berends AMA, et al. Among authors: van schaik rhn. Biomedicines. 2022 Apr 13;10(4):896. doi: 10.3390/biomedicines10040896. Biomedicines. 2022. PMID: 35453646 Free PMC article.
A pharmacogenetic predictive model for paclitaxel clearance based on the DMET platform.
de Graan AJ, Elens L, Smid M, Martens JW, Sparreboom A, Nieuweboer AJ, Friberg LE, Elbouazzaoui S, Wiemer EA, van der Holt B, Verweij J, van Schaik RH, Mathijssen RH. de Graan AJ, et al. Clin Cancer Res. 2013 Sep 15;19(18):5210-7. doi: 10.1158/1078-0432.CCR-13-0487. Epub 2013 Aug 5. Clin Cancer Res. 2013. PMID: 23918604
Predicting paclitaxel-induced neutropenia using the DMET platform.
Nieuweboer AJ, Smid M, de Graan AJ, Elbouazzaoui S, de Bruijn P, Martens JW, Mathijssen RH, van Schaik RH. Nieuweboer AJ, et al. Pharmacogenomics. 2015;16(11):1231-41. doi: 10.2217/pgs.15.68. Epub 2015 Aug 12. Pharmacogenomics. 2015. PMID: 26265135
Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.
Nieuweboer AJ, Smid M, de Graan AM, Elbouazzaoui S, de Bruijn P, Eskens FA, Hamberg P, Martens JW, Sparreboom A, de Wit R, van Schaik RH, Mathijssen RH. Nieuweboer AJ, et al. Pharmacogenomics J. 2016 Nov;16(6):519-524. doi: 10.1038/tpj.2015.66. Epub 2015 Sep 8. Pharmacogenomics J. 2016. PMID: 26345519
Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients.
Bins S, Basak EA, El Bouazzaoui S, Koolen SLW, Oomen-de Hoop E, van der Leest CH, van der Veldt AAM, Sleijfer S, Debets R, van Schaik RHN, Aerts JGJV, Mathijssen RHJ. Bins S, et al. Among authors: van der leest ch, van der veldt aam, van schaik rhn. Br J Cancer. 2018 May;118(10):1296-1301. doi: 10.1038/s41416-018-0074-1. Epub 2018 Apr 26. Br J Cancer. 2018. PMID: 29695768 Free PMC article.
Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial).
van der Schans J, Hak E, Postma M, Breuning L, Brouwers JRBJ, Ditters K, Jansen PAF, Kok RM, Maring JG, van Marum R, Mulder H, Nanninga J, Oude Voshaar RC, Risselada AJ, Vleugel L, Stek M, van Schaik RHN, Berm EJJ, Wilffert B. van der Schans J, et al. Among authors: van schaik rhn, van marum r. J Clin Psychopharmacol. 2019 Nov/Dec;39(6):583-590. doi: 10.1097/JCP.0000000000001129. J Clin Psychopharmacol. 2019. PMID: 31688392 Clinical Trial.
The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer.
Belderbos BPS, de With M, Singh RK, Agema BC, El Bouazzaoui S, Oomen-de Hoop E, de Wit R, van Schaik RHN, Mathijssen RHJ, Bins S. Belderbos BPS, et al. Among authors: van schaik rhn. Cancer Chemother Pharmacol. 2020 Mar;85(3):547-553. doi: 10.1007/s00280-019-04011-0. Epub 2020 Jan 1. Cancer Chemother Pharmacol. 2020. PMID: 31893292 Clinical Trial.
Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer.
Hurkmans DP, Basak EA, Schepers N, Oomen-De Hoop E, Van der Leest CH, El Bouazzaoui S, Bins S, Koolen SLW, Sleijfer S, Van der Veldt AAM, Debets R, Van Schaik RHN, Aerts JGJV, Mathijssen RHJ. Hurkmans DP, et al. Among authors: van der leest ch, van der veldt aam, van schaik rhn. J Immunother Cancer. 2020 May;8(1):e000586. doi: 10.1136/jitc-2020-000586. J Immunother Cancer. 2020. PMID: 32461348 Free PMC article.
408 results